Vol. 58 No. 6 (2019): Acta Oncologica

Articles

• Obesity and chemotherapy administration: between empiric and mathematic method review

  W. Bouleftour, B. Mery, E. Chanal, E. Rowinski, A. Viard, F. Forges, P. Fournel, R. Rivoirard

  880-887

  Published: 2019-06-03

  • PDF

• Reduced inter-observer and intra-observer delineation variation in esophageal cancer radiotherapy by use of fiducial markers

  Mélanie Machiels, Peng Jin, Jeanin E. van Hooft, Oliver J. Gurney-Champion, Pouya Jelvehgaran, Elizabeth D. Geijsen, Paul M. Jeene, M. Willemijn Kolff, Vera Oppedijk, Coen. R. N. Rasch, Marcel B. van Herk, Tanja Alderliesten, Maarten C. C. M. Hulshof

  943-950

  Published: 2019-06-03

  • PDF

• Potential skin morbidity reduction with intensity-modulated proton therapy for breast cancer with nodal involvement

  Francesco Fellin, Martina Iacco, Vittoria D'Avino, Francesco Tommasino, Paolo Farace, Giuseppe Palma, Manuel Conson, Irene Giacomelli, Claudio Zucchetti, Lorenzo Falcinelli, Maurizio Amichetti, Cynthia Aristei, Laura Cella

  934-942

  Published: 2019-06-03

  • PDF

• Long-term outcomes following stereotactic body radiotherapy boost for oropharyngeal squamous cell carcinoma

  Sarah Baker, Gerda M. Verduijn, Steven Petit, Aniel Sewnaik, Hetty Mast, Senada Koljenović, Joost J. Nuyttens, Wilma D. Heemsbergen

  926-933

  Published: 2019-06-03

  • PDF

• Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis

  Almut Dutz, Linda Agolli, Michael Baumann, Esther G. C. Troost, Mechthild Krause, Tobias Hölscher, Steffen Löck

  916-925

  Published: 2019-06-03

  • PDF

• Geometrical tracking accuracy and appropriate PTV margins for robotic radiosurgery of liver lesions by SBRT

  Ming Liu, Joanna E. Cygler, Eric Vandervoort

  906-915 |

  Published: 2019-06-03

  • PDF

• Sirolimus monotherapy for Erdheim–Chester disease

  Eric F. H. van Bommel, Mark A. van der Zijden, Peter J. H. Smak Gregoor, Tadek R. Hendriksz, Shiuw H. Ho-Han, Pieter J. Westenend

  901-905

  Published: 2019-06-03

  • PDF

• The CDK 4/6 inhibitor ribociclib has activity in the treatment of inoperable desmoid tumor. A case report

  Kirsi Santti, Annette Beule, Mikko Rönty, Hanna Ihalainen, Maija Tarkkanen, Carl Blomqvist

  897-900

  Published: 2019-06-03

  • PDF

• Satisfaction with information on nilotinib treatment in chronic myeloid leukemia patients

  Christel C. L. M. Boons, Vashti N. M. F. Tromp, Nienke J. M. Neppelenbroek, Lonneke Timmers, Natasja M. van Schoor, Eleonora L. Swart, N. Harry Hendrikse, Jeroen J. W. M. Janssen, Jacqueline G. Hugtenburg

  891-896

  Published: 2019-06-03

  • PDF

• Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy

  Pasquale Niscola, Nélida Inés Noguera, Gianfranco Catalano, Luca Cupelli, Stefano Fratoni, Marco Giovannini, Carla Mazzone, Benedetta Neri, Laura Scaramucci, Malgorzata Monika Trawinska, Paolo de Fabritiis, Elisabetta Abruzzese

  888-890

  Published: 2019-06-03

  • PDF

• Publishing your trial protocols with Acta Oncologica; your contribution to scientific transparency

  Mef Nilbert, Jens Overgaard

  821

  Published: 2019-06-03

  • PDF

• Association of pazopanib-induced toxicities with outcome of patients with advanced soft tissue sarcoma; a retrospective analysis based on the European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 clinical trials

  Melissa Vos, Stefan Sleijfer, Saskia Litière, Nathan Touati, Florence Duffaud, Winette T. van der Graaf, Hans Gelderblom

  872-879

  Published: 2019-06-03

  • PDF

• The effect of postoperative gemcitabine on overall survival in patients with resected pancreatic cancer: A nationwide population-based Danish register study

  Louise Skau Rasmussen, Benny Vittrup, Morten Ladekarl, Per Pfeiffer, Mette Karen Yilmaz, Laurids Østergaard Poulsen, Kell Østerlind, Carsten Palnæs Hansen, Michael Bau Mortensen, Frank Viborg Mortensen, Mogens Sall, Sönke Detlefsen, Martin Bøgsted, Claus Wilki Fristrup

  864-871

  Published: 2019-06-03

  • PDF

• Cancer incidence and mortality after heart transplantation – A population-based national cohort study

  Salla Jäämaa-Holmberg, Birgitta Salmela, Karl Lemström, Eero Pukkala, Jyri Lommi

  859-863

  Published: 2019-06-03

  • PDF

• Use of phthalate-containing prescription drugs and the risk of gastric cancer: a Danish nationwide case-control study

  Zandra Nymand Ennis, Sidsel Arnspang Pedersen, Morten Rix Hansen, Anton Pottegård, Thomas Patrick Ahern, Jesper Hallas, Per Damkier

  852-858

  Published: 2019-06-03

  • PDF

• Sociodemographic disparities in stage-specific incidences of endometrial cancer: a registry-based study in West Sweden, 1995–2016

  Teresia Svanvik, Janusz Marcickiewicz, Karin Sundfeldt, Erik Holmberg, Ulf Strömberg

  845-851 |

  Published: 2019-06-03

  • PDF

• Second cancers in radically treated Norwegian prostate cancer patients

  Bjørg Y. Aksnessæther, Jo-Åsmund Lund, Tor Åge Myklebust, Olbjørn H. Klepp, Eva Skovlund, Solveig Roth Hoff, Arne Solberg

  838-844

  Published: 2019-06-03

  • PDF

• Pharmacokinetic analysis of DCE-MRI data of locally advanced cervical carcinoma with the Brix model

  Kjersti V. Lund, Trude G. Simonsen, Gunnar B. Kristensen, Einar K. Rofstad

  828-837

  Published: 2019-06-03

  • PDF

• Incidence and inheritance of hyperphosphorylated paratarg-7 in patients with Waldenstrom’s macroglobulinaemia in Sweden

  Lena Brandefors, Jack Lindh, Klaus-Dieter Preuss, Natalie Fadle, Michael Pfreundschuh, Eva Kimby

  824-827

  Published: 2019-06-03

  • PDF

• Continuous development of colorectal cancer screening programs

  Geir Hoff, Giske Ursin, Magnus Løberg, Thomas de Lange, Eva Skovlund, Øyvind Holme

  822-823 |

  Published: 2019-06-03

  • PDF